In a vitro experiment, the researchers established that tetrahydroxycurcumin prevents the spread and invasion of human ovarian cancer cells SKOV3 by regulating the expression of CXCR4 and CXCL‐12 (Mohamadian et al. 2022). This evidence concerns the gene CXCR4 and ovarian carcinoma.